Charlotte E Joslin1, Katherine C Brewer2, Faith G Davis3, Kent Hoskins4, Caryn E Peterson2, Heather A Pauls5. 1. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, United States; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, United States; University of Illinois at Chicago Cancer Center, Cancer Control and Population Science Research Program, United States. Electronic address: charjosl@uic.edu. 2. Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, United States. 3. School of Public Health, University of Alberta, Canada. 4. University of Illinois at Chicago Cancer Center, Cancer Control and Population Science Research Program, United States; Department of Hematology/Oncology, University of Illinois at Chicago, United States. 5. Institute for Health Research and Policy (IHRP), University of Illinois at Chicago, United States.
Abstract
BACKGROUND: Less than half of women with ovarian cancer and blacks specifically receive therapy adherent to National Comprehensive Cancer Network (NCCN) guidelines. The purpose is to assess the effect of neighborhood-level socioeconomic status (SES) on black-white treatment differences in a population-based analysis in a highly-segregated community. METHODS: Illinois State Cancer Registry data for invasive epithelial ovarian cancer cases diagnosed in Cook County, IL in non-Hispanic white (NHW) or black (NHB) women from 1998 to 2009 was analyzed. As few women receive NCCN-adherent care, variables were constructed to assess extent of treatment, including receipt of: 1) debulking surgery; 2) any surgery; 3) multi-agent chemotherapy; and 4) any chemotherapy. Two measures (concentrated affluence and disadvantage) were used to estimate neighborhood-level SES. Multivariable logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (95% CI), with generalized linear mixed models to account for hierarchical data. RESULTS: 2766 (81.0%) NHW and 647 (19.0%) NHB women were diagnosed. Adjusting for covariates, NHB were less likely to receive debulking surgery (OR: 0.39; 95% CI: 0.30-0.50), any surgery (OR: 0.38; 95%CI: 0.29-0.49), multi-agent chemotherapy (OR: 0.56; 95% CI: 0.45-0.71) and any chemotherapy (OR: 0.58; 95% CI: 0.45-0.74). Concentrated affluence but not disadvantage was significant in final models for multi-agent and any chemotherapy, but not debulking or any surgery. CONCLUSIONS: Results identify black-white differences consistent across treatments that persist despite adjustment for neighborhood-level SES. IMPACT: Results advance inequality awareness beyond "ideal" NCCN-adherent care, indicating inequality exists in delivery of even the most basic oncologic care.
BACKGROUND: Less than half of women with ovarian cancer and blacks specifically receive therapy adherent to National Comprehensive Cancer Network (NCCN) guidelines. The purpose is to assess the effect of neighborhood-level socioeconomic status (SES) on black-white treatment differences in a population-based analysis in a highly-segregated community. METHODS: Illinois State Cancer Registry data for invasive epithelial ovarian cancer cases diagnosed in Cook County, IL in non-Hispanic white (NHW) or black (NHB) women from 1998 to 2009 was analyzed. As few women receive NCCN-adherent care, variables were constructed to assess extent of treatment, including receipt of: 1) debulking surgery; 2) any surgery; 3) multi-agent chemotherapy; and 4) any chemotherapy. Two measures (concentrated affluence and disadvantage) were used to estimate neighborhood-level SES. Multivariable logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (95% CI), with generalized linear mixed models to account for hierarchical data. RESULTS: 2766 (81.0%) NHW and 647 (19.0%) NHB women were diagnosed. Adjusting for covariates, NHB were less likely to receive debulking surgery (OR: 0.39; 95% CI: 0.30-0.50), any surgery (OR: 0.38; 95%CI: 0.29-0.49), multi-agent chemotherapy (OR: 0.56; 95% CI: 0.45-0.71) and any chemotherapy (OR: 0.58; 95% CI: 0.45-0.74). Concentrated affluence but not disadvantage was significant in final models for multi-agent and any chemotherapy, but not debulking or any surgery. CONCLUSIONS: Results identify black-white differences consistent across treatments that persist despite adjustment for neighborhood-level SES. IMPACT: Results advance inequality awareness beyond "ideal" NCCN-adherent care, indicating inequality exists in delivery of even the most basic oncologic care.
Authors: Eva J A Morris; Elizabeth F Taylor; James D Thomas; Philip Quirke; Paul J Finan; Michel P Coleman; Bernard Rachet; David Forman Journal: Gut Date: 2011-04-12 Impact factor: 23.059
Authors: Sydney M Dy; Phoebe Sharkey; Robert Herbert; Kathleen Haddad; Albert W Wu Journal: Crit Rev Oncol Hematol Date: 2006-07-07 Impact factor: 6.312
Authors: H R Balvert-Locht; J W Coebergh; W C Hop; H A Brölmann; M Crommelin; D J van Wijck; M T Verhagen-Teulings Journal: Gynecol Oncol Date: 1991-07 Impact factor: 5.482
Authors: David Ansell; Paula Grabler; Steven Whitman; Carol Ferrans; Jacqueline Burgess-Bishop; Linda Rae Murray; Ruta Rao; Elizabeth Marcus Journal: Cancer Causes Control Date: 2009-08-18 Impact factor: 2.506
Authors: Philip J Lupo; Heather E Danysh; Elaine Symanski; Peter H Langlois; Yi Cai; Michael D Swartz Journal: Am J Public Health Date: 2015-10-15 Impact factor: 9.308
Authors: Katherine C Brewer; Caryn E Peterson; Faith G Davis; Kent Hoskins; Heather Pauls; Charlotte E Joslin Journal: Ann Epidemiol Date: 2015-04-18 Impact factor: 3.797
Authors: Tomi Akinyemiju; Justin Xavier Moore; Akinyemi I Ojesina; John W Waterbor; Sean F Altekruse Journal: Breast Cancer Res Treat Date: 2016-06-02 Impact factor: 4.872
Authors: Caryn E Peterson; Garth H Rauscher; Timothy P Johnson; Carolyn V Kirschner; Sally Freels; Richard E Barrett; Seijeoung Kim; Marian L Fitzgibbon; Charlotte E Joslin; Faith G Davis Journal: Front Public Health Date: 2015-01-22
Authors: Shama Karanth; Mackenzie E Fowler; XiHua Mao; Lauren E Wilson; Bin Huang; Maria Pisu; Arnold Potosky; Tom Tucker; Tomi Akinyemiju Journal: JNCI Cancer Spectr Date: 2019-10-09
Authors: Kristen A Sorice; Carolyn Y Fang; Daniel Wiese; Angel Ortiz; Yuku Chen; Kevin A Henry; Shannon M Lynch Journal: Cancer Med Date: 2022-02-14 Impact factor: 4.711